how do glp 1 cause weight loss GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for and Obesity Weight Reduction with GLP-1 Agonists

Utz et al., 2008)

We can prescribe with appropriate BMI (typically 27+ with comorbidities, or 30+ without) after evaluation

Systematic Reviews and Meta-analyses One collaborative meta-analysis that synthesized the cardiovascular outcomes reported the results from four studies and 45,568 patients on the add-on therapy modalities [20]

The most common side effects include nausea, constipation, bloating, reduced appetite, fatigue, and mild headaches

A clinical study involving 564 adults (BMI 30-40 kg/m2, without T2DM) found that compared with orlistat (3120 mg, weight loss of 4.1 kg), LIR (subcutaneous administration of 1.2 mg/d, 1.8 mg/d, 2.4 mg/d or 3 mg/d) had an average weight loss of 4.8-7.2 kg, the two-year extended experiment of which also showed similar results (88, 89)

Microdosing vs standard dosing: a direct comparison How do these approaches actually stack up against each other